Status | Study |
NOT_YET_RECRUITING |
Study Name: Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT� Condition: Date: 2023-05-16 Interventions: Coagulation Factor VIIa (Recombinant) |
RECRUITING |
Study Name: Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT� Condition: Hemophilia Date: 2023-05-16 Interventions: Coagulation Factor VIIa (Recombinant) |
Completed |
Study Name: Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients Condition: Hemophilia Date: 2022-12-28 Interventions: Interventional |
RECRUITING |
Study Name: A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM Condition: Hemophilia Date: 2022-12-21 Interventions: LR769 |
RECRUITING |
Study Name: A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia Condition: Hemophilia Date: 2022-12-14 Interventions: Pharmaceutical form: Solution for injection Route of administration: Subcutaneous (SC) |
RECRUITING |
Study Name: A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions Condition: Hemophilia Date: 2022-06-24 Interventions: VR-based solution comprises a mobile phone application including explanation on the different steps to be followed to perform infusions in satisfactor |
RECRUITING |
Study Name: Trial of an Exercise Intervention for Children With Haemophilia Condition: Date: 2020-07-21 Interventions: 12-week exercise intervention |
Recruiting |
Study Name: Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." Condition: Hemophilia A Date: 2015-10-20 Interventions: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222) |
Active, not recruiting |
Study Name: National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A Condition: Hemophilia A Date: 2015-07-17 Interventions: Behavioral: Educational Package Patients will be invited to attend a PK educational session as part of t |
Active, not recruiting |
Study Name: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B Condition: Hemophilia B Date: 2015-03-04 Interventions: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name: |